LMAT
Price
$97.23
Change
-$0.26 (-0.27%)
Updated
Sep 8, 01:00 PM (EDT)
Capitalization
2.21B
52 days until earnings call
SOLV
Price
$74.85
Change
+$2.13 (+2.93%)
Updated
Sep 8, 01:30 PM (EDT)
Capitalization
12.61B
59 days until earnings call
Interact to see
Advertisement

LMAT vs SOLV

Header iconLMAT vs SOLV Comparison
Open Charts LMAT vs SOLVBanner chart's image
LeMaitre Vascular
Price$97.23
Change-$0.26 (-0.27%)
Volume$100
Capitalization2.21B
Solventum
Price$74.85
Change+$2.13 (+2.93%)
Volume$500
Capitalization12.61B
LMAT vs SOLV Comparison Chart in %
Loading...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LMAT vs. SOLV commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMAT is a StrongBuy and SOLV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (LMAT: $97.49 vs. SOLV: $72.72)
Brand notoriety: LMAT and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: LMAT: 87% vs. SOLV: 73%
Market capitalization -- LMAT: $2.21B vs. SOLV: $12.61B
LMAT [@Pharmaceuticals: Other] is valued at $2.21B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $12.61B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LMAT’s FA Score shows that 1 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).

  • LMAT’s FA Score: 1 green, 4 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, LMAT is a better buy in the long-term than SOLV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LMAT’s TA Score shows that 5 TA indicator(s) are bullish while SOLV’s TA Score has 5 bullish TA indicator(s).

  • LMAT’s TA Score: 5 bullish, 5 bearish.
  • SOLV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than LMAT.

Price Growth

LMAT (@Pharmaceuticals: Other) experienced а +2.23% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -0.51% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.00%. For the same industry, the average monthly price growth was +4.50%, and the average quarterly price growth was +17.54%.

Reported Earning Dates

LMAT is expected to report earnings on Oct 30, 2025.

SOLV is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLV($12.6B) has a higher market cap than LMAT($2.21B). LMAT has higher P/E ratio than SOLV: LMAT (47.56) vs SOLV (33.36). SOLV YTD gains are higher at: 10.082 vs. LMAT (6.543). LMAT has less debt than SOLV: LMAT (185M) vs SOLV (7.82B).
LMATSOLVLMAT / SOLV
Capitalization2.21B12.6B18%
EBITDAN/A1.28B-
Gain YTD6.54310.08265%
P/E Ratio47.5633.36143%
RevenueN/A8.39B-
Total CashN/A492M-
Total Debt185M7.82B2%
FUNDAMENTALS RATINGS
LMAT: Fundamental Ratings
LMAT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LMATSOLV
RSI
ODDS (%)
Bearish Trend 4 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
67%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
77%
MACD
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
63%
Declines
ODDS (%)
Bearish Trend 6 days ago
53%
Bearish Trend 6 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
56%
Bullish Trend 7 days ago
88%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SOLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHXAX15.640.19
+1.23%
American Beacon Shapiro Equity Opps A
MWOFX64.730.07
+0.11%
MFS Global Growth A
APDLX15.49-0.03
-0.19%
Artisan Value Advisor
ACARX39.37-0.09
-0.23%
Alger Capital Appreciation Instl R
FKGRX148.13-0.50
-0.34%
Franklin Growth A

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
+0.43%
ITGR - LMAT
47%
Loosely correlated
+0.32%
SYK - LMAT
47%
Loosely correlated
-0.51%
UFPT - LMAT
45%
Loosely correlated
-0.75%
AORT - LMAT
41%
Loosely correlated
-1.23%
SOLV - LMAT
38%
Loosely correlated
+0.47%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+0.47%
NVST - SOLV
52%
Loosely correlated
+2.55%
BAX - SOLV
51%
Loosely correlated
+3.56%
AZTA - SOLV
46%
Loosely correlated
+2.64%
RMD - SOLV
46%
Loosely correlated
+1.18%
ALC - SOLV
43%
Loosely correlated
+1.60%
More